Gainers

  • Quoin Pharmaceuticals QNRX shares moved upwards by 25.7% to $6.3 during Wednesday's pre-market session. The company's market cap stands at $9.0 million.
  • Eargo EAR shares increased by 21.78% to $2.46. The company's market cap stands at $96.8 million.
  • Cassava Sciences SAVA stock moved upwards by 20.18% to $24.29. The market value of their outstanding shares is at $973.9 million.
  • Endo International ENDP stock moved upwards by 15.94% to $0.43. The market value of their outstanding shares is at $100.8 million.
  • Eton Pharmaceuticals ETON shares increased by 15.18% to $2.73. The market value of their outstanding shares is at $69.0 million. The company's, Q2 earnings came out 4 days ago.
  • PLx Pharma PLXP shares rose 12.49% to $1.26. The market value of their outstanding shares is at $35.4 million. As per the press release, Q2 earnings came out 3 days ago.

Losers

  • Artelo Biosciences ARTL shares declined by 14.9% to $5.41 during Wednesday's pre-market session. The company's market cap stands at $15.3 million.
  • Blueprint Medicines BPMC shares fell 13.94% to $59.0. The market value of their outstanding shares is at $3.5 billion.
  • PAVmed PAVM stock fell 10.11% to $1.78. The company's market cap stands at $161.9 million. As per the press release, Q2 earnings came out yesterday.
  • Unity Biotechnology UBX stock fell 8.76% to $1.25. The market value of their outstanding shares is at $87.0 million. The company's, Q2 earnings came out 3 days ago.
  • Eloxx Pharmaceuticals ELOX shares fell 8.54% to $0.38. The company's market cap stands at $32.4 million. As per the news, the Q2 earnings report came out 2 days ago.
  • T2 Biosystems TTOO shares fell 8.46% to $0.15. The market value of their outstanding shares is at $25.4 million. The company's, Q2 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!